These data suggest that the pathologic changes occurring in AD brains are the result of a combination of molecular mechanisms involving not only Aβ peptides but also additional molecules, such as tau and other unexplored or thoroughly unknown factors. The gene discussed is MAPT; the disease is Alzheimer disease.